• Dispensing of Vitamin Products by Retail Pharmacies in South Africa

    Nov 1, 2015, 00:00

  • Closing The Financial Gap of Antiretroviral and Hiv Supplies For Sustainability of Hiv National Response In The Dominican Republic

    Nov 1, 2015, 00:00

  • Indicação Do Medicamento Talidomida Para O Tratamento De Mieloma Múltiplo- Uma Avaliação Para Atualização Da Rename

    Nov 1, 2015, 00:00

  • Relationship Between Adherence To Post Percutaneous Coronary Intervention (Pci) Guidelines And Clinical Outcomes Of Post-Pci Patients In Hong Kong - A 5-Year Retrospective Cohort Study

    Nov 1, 2015, 00:00

  • Current Process and Future Path for Health Economic Assessment of Pharmaceuticals in France

    Nov 1, 2015, 00:00

  • Resource Use And Exacerbations Of Chronic Obstructive Pulmonary Disease (Copd) By Gold Categories

    Nov 1, 2015, 00:00

  • Systematic Review and Cost-Effectiveness Analysis of Drug Used in Obesity Treatment in Brazil, Under Health System Perspective

    Nov 1, 2015, 00:00

  • Comparison of Direct Hospitalization Costs and Length of Stay In Carbapenem Resistant Versus Carbapenem Sensitive Klebsiella Pneumoniae Infections In A Tertiary Care Hospital

    Nov 1, 2015, 00:00

  • The Challenges of Carrying out an Indirect Comparison with Single-Arm Studies

    Nov 1, 2015, 00:00

  • Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking once Daily Teriflunomide Tablets in the United States

    Nov 1, 2015, 00:00

  • Systematic Literature Review of the Burden of Illness in Hypertriglyceridemia

    Nov 1, 2015, 00:00

  • Costs Analysis Of Pcr Unyverotm I60-Iti Technique For Detecting Microorganisms In Patients With Suspected Chronic Infection At Musculoskeletal Implants

    Nov 1, 2015, 00:00

  • Purpose, Belief And Rate of Disclosure of Cam Use Among Diabetic Patients In Quetta, Pakistan

    Nov 1, 2015, 00:00

  • Cognitive Debriefing And Usability Assessment Of The Eortc Qlq-C30 And Qlq-Br23 As Presented On Tablet And Handheld Devices

    Nov 1, 2015, 00:00

  • The Economics Of Critical Care Diagnostics- The Case Of Procalcitonin-Guided Care In Treatment Of Acute Respiratory Infection In The U.S

    Nov 1, 2015, 00:00

  • Economic Evaluation of Voriconazole in the Treatment of Invasive Aspergillosis

    Nov 1, 2015, 00:00

  • Medical Cost Associated with Treatment and Follow-Up of Pantients with Head and Neck Cancer

    Nov 1, 2015, 00:00

  • What Is Ce Marking? How Technologies Are Classified, And How To Navigate The System

    Nov 1, 2015, 00:00

  • Evaluacion economica de tres terapias para la enfermedad pulmonar obstructiva cronica en chile. Análisis de costo utilidad

    Nov 1, 2015, 00:00

  • Variation In State-Level Vs. National Incidence In Rare Genetic Disease- A Monte Carlo Simulation to Examine Sampling Variation As A Primary Explanation In Congenital Adrenal Hyperplasia

    Nov 1, 2015, 00:00

  • Are the Irish Slower than they Think? A Systematic Analysis of all Recent Ncpe Appraisals

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Evaluation Comparing Biosimilar Bemfola to Gonal-F for the Treatment of Infertility in an Italian Contest

    Nov 1, 2015, 00:00

  • Cost-Effectiveness and Cost-Utility Analyses Comparing Strategies for Initial Treatment of Rheumatoid Arthritis Using Published Outcomes- Economic Lessons From The Tear Trial

    Nov 1, 2015, 00:00

  • Achievement of Glycaemic Targets with Canagliflozin in Triple Therapy in Patients with Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis of Gefitinib as the First Line Treatment in Patients With Positive Egfr Mutation In Metastatic or Locally Advanced non-Small Cell

    Nov 1, 2015, 00:00

  • Clinical And Economic Analysis Of Effectiveness Of Fondaparinux Sodium In The Treatment Of Acute Coronary Syndrome

    Nov 1, 2015, 00:00

  • Risk of Incident Chronic Kidney Disease and End-Stage Renal Disease in Patients with Psoriasis- a Nationwide Population-Based Cohort Study

    Nov 1, 2015, 00:00

  • Economic Burden of Type 2 Diabetes Mellitus For Mexico

    Nov 1, 2015, 00:00

  • Economic Analysis Of Evarrest® Sealant Matrix Compared With Standard Of Care In Severe Soft Tissue Surgical Bleeding- A German Hospital Perspective

    Nov 1, 2015, 00:00

  • Multi European Country Cost Consequence Comparison Of Floseal Matrix And Surgiflo Thrombin In Major And Severe Spine Surgeries

    Nov 1, 2015, 00:00

  • Efficiency Assessments of Pharmaceuticals and Medical Devices In Fran A 2 Years Update

    Nov 1, 2015, 00:00

  • Survey on Romanian Hospitals Financing Reveals Major Dysfunctions In Covering Drug Treatment During Hospitalization

    Nov 1, 2015, 00:00

  • Systematic Literature Review of Adjunctive Anti-Epileptic Drug Trials In Patients With Primary Generalized Tonic-Clonic Seizures Illustrates Changes in Standard of Care Over 12-20 Years

    Nov 1, 2015, 00:00

  • A Review of Patient Registries in Heart Failure Across European Union-5 Countries

    Nov 1, 2015, 00:00

  • Do Patient Reported Outcomes (Pro) In Oncology Matter In Health Technology Assessments (Hta)?

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Vemurafenib Vs Ipilimumab Plus Dacarbacine in the Treatment of Non-Resectable Metastasic Melanoma with Braf600e Mutation in Colombia

    Nov 1, 2015, 00:00

  • Opioid Addiction Treatment in the eu5- Market Access Levers for Emerging Brands Entering a Generic Market

    Nov 1, 2015, 00:00

  • Atrial Fibrillation And Anti-Coagulation Service Run By A Clinical Nurse Specialist

    Nov 1, 2015, 00:00

  • When is it Evening, When is it Night? why it is Challenging to Translate Times of the Day in Clinical Translations

    Nov 1, 2015, 00:00

  • Data Mining Based On Real World Data In Chronic Kidney Disease Patients Not On Dialysis- The Key Role Of Early Hemoglobin Levels Control

    Nov 1, 2015, 00:00

  • Utility Values for Health Technology Assessment- Learning Lessons from Economic Models of Pharmaceuticals Submitted to the French National Authority for Health (Has)

    Nov 1, 2015, 00:00

  • Review and Comparison of Eq-5d-3l Valuation Studies

    Nov 1, 2015, 00:00

  • Five-Years Experience of Robotic Vs Laparoscopic Colorectal Cancer Surgery in a Single Center- Surgical Parameters and Costs

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Obinutuzumab/Chlorambucil Vs Rituximab/Chlorambucil In Treatment Of Chronic Lymphocytic Leukemia

    Nov 1, 2015, 00:00

  • Review Of Comorbidity Measures To Predict Economic Outcomes In Real-Life Database Studies

    Nov 1, 2015, 00:00

  • Assessment of Direct Cost for Treatment of Influenza and Ari for Outpatient In Ukraine

    Nov 1, 2015, 00:00

  • Cancer And Premature Mortality In Ireland- An Employer’s Perspective Following The Friction Cost Approach

    Nov 1, 2015, 00:00

  • Qualitative Equivalence Between Paper and Ediary Versions and Usability of 6 Pro Questionnaires for Endometriosis

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Intravitreal Aflibercept Compared with Ranibizumab-Prn in Patients with wet Age-Related Macular Degeneration (Wamd)

    Nov 1, 2015, 00:00

  • International Comparison of Internet Information Source in Breast Cancer

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Apixaban Versus Other Noacs And Warfarin, During Hospitalization In The Private Brazilian Health System

    Nov 1, 2015, 00:00

  • Children’s Medication In The Nordic Countries – Survey on National Administrative Register Data

    Nov 1, 2015, 00:00

  • Romania’s New HTA System- What Progress have Innovative Drugs Made under the Points-Based System So Far?

    Nov 1, 2015, 00:00

  • Survey of the Hungarian Physiotherapists’ Migration and Career Changing Behaviour

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Neo-Adjuvant Pertuzumab Therapy In Women With Locally Advanced, Inflammatory, Or Early Her2-Positive Breast Cancer In Italy

    Nov 1, 2015, 00:00

  • Using Tangent Line Segments to Determine Statistical Differences between Survival Curves at a Single Point in Time

    Nov 1, 2015, 00:00

  • The Diabetes Telephone Study- Design and Challenges of a Pragmatic Cluster Randomized Trial to Improve Diabetic Peripheral Neuropathy Treatment

    Nov 1, 2015, 00:00

  • Building Intentions with The Theory of Planned Behaviour- A Qualitative Assessment of Salient Beliefs About Pharmacy Value Added Services in Malaysia

    Nov 1, 2015, 00:00

  • Zrx Mcdm- A Fully Flexible Tool to Support The Local Adaptation of Multiple-Criteria Decision Criteria In Health Care

    Nov 1, 2015, 00:00

  • Assessment of Who/Inrud Core Drug Use Indicators in two Tertiary Care Hospitals of Bahawalpur, Punjab, Pakistan

    Nov 1, 2015, 00:00

  • Weight Loss Treatment Patterns in Mexico

    Nov 1, 2015, 00:00

  • Real World Data- Biologic Treatment for Naive Patient in the Lazio Region

    Nov 1, 2015, 00:00

  • Differential Pricing For Pharmaceuticals- Overview Of A Widely Debated Pricing Concept And Key Challenges

    Nov 1, 2015, 00:00

  • Fluticasone Propionate Versus Budesonide or Beclomethasone As Monotherapy Treatment for Asthma Patients - A Systematic Review

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Capsule Endoscopy Using For Diagnosing Small Bowel Crohn’s Disease

    Nov 1, 2015, 00:00

  • Bayesian Econometric Modelling Of Observational Data For Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00

  • Cost Reduction For A Health System Through Decreasing Number Of Eligible Patients For Biological Therapy In Patients With Rheumatoid Arthritis Using The Treat To Target Recommendations

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Treatments for Wet Age-Related Macular Degeneration (Wamd) In The Netherlands, The Case of Intravitreal Aflibercept (Ivt-Afl) and Ranibizumab

    Nov 1, 2015, 00:00

  • Choice of Antithrombotic Drug in non-Valvular Atrial Fibrillation Patients in Real-World Practice

    Nov 1, 2015, 00:00

  • The Economic Consequences Of The Use Of Antibiotics In Belgium

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of One-Piece Drainable Pouch Versus Two-Piece Drainable Pouch For Colostomates Under The Perspective of Patient’s Out-of-Pocket Expenses, In Brazil

    Nov 1, 2015, 00:00

  • A Review of Guidelines And Approaches to Performance-Based Risk-Sharing Agreements Across The Uk, Italy And The Netherlands

    Nov 1, 2015, 00:00

  • Adherence of hiv patients switching to emtricitabina+tenofovir disoproxil+rilpivirin. Real world evidence from italian administrative databases

    Nov 1, 2015, 00:00

  • Treatment Continuation And Treatment Characteristics Of Four Long Acting Antipsychotic Medications (Paliperidone Palmitate, Risperidone Microspheres, Olanzapine Pamoate And Haloperidol Decanoate) In The Netherlands

    Nov 1, 2015, 00:00

  • Costing The National Health Insurance Program Prematurity Benefit Package- The Philippine Experience

    Nov 1, 2015, 00:00

  • Análisis de Costo Efectividad y Costo Utilidad de Rituximab Como Tratamiento en Pacientes Con Artritis Reumatoide, Ante el Fallo o Intolerancia en Primera Línea de un Anti-Tnf, en el Contexto Venezolano

    Nov 1, 2015, 00:00

  • Costo De Tuberculosis En Los Establecimientos De Salud Del Perú

    Nov 1, 2015, 00:00

  • Are Medicines Granted with a Conditional Approval by the European Medicines Agency Gaining Positive Assessment by Payers in France, Germany and the United Kingdom?

    Nov 1, 2015, 00:00

  • Social Impact of Psoriasis In Spain- A Rasch Analysis From A Survey

    Nov 1, 2015, 00:00

  • Hurdles That Impede Economic Evaluations of Health Care Interventions Tested By General Practitioners In Flanders- A Qualitative Study

    Nov 1, 2015, 00:00

  • Analysis of Direct Costs Associated With Cystic Fibrosis In Single Center In Slovakia- 5 Years Review

    Nov 1, 2015, 00:00

  • Cost Analysis of Two Methods for Improving the Quality of Care (Qoc) Scores in Paediatric Hospital Wards During Winter Periods

    Nov 1, 2015, 00:00

  • Assessment of Health Related Quality of Life (Hrql) Using Eq-5d In Type 2 Diabetes Mellitus Patients In A University Teaching Hospital

    Nov 1, 2015, 00:00

  • How to Calculate Value of Information in Seconds Using ‘Savi’, the Sheffield Accelerated Value of Information Web App

    Nov 1, 2015, 00:00

  • The Cost-Of-Disease (Cod) In Wet Age-Related Macular Degeneration (Wamd) In Turkey- An Expert Panel Approach for Estimation of Costs

    Nov 1, 2015, 00:00

  • Clinical And Health-Economic Criteria for the Assessment of New Immune-Oncologic Drugs in Spain

    Nov 1, 2015, 00:00

  • Sofosbuvir- The Failure of Pricing Policies In The European Union

    Nov 1, 2015, 00:00

  • A Systematic Review of Model-Based Economic Evaluations of Drug Substitution Therapies in Maintenance Treatment of Non-Prescription Opioid Dependence

    Nov 1, 2015, 00:00

  • Hospitalization Expenses Analysis Of Chinese Stroke Patients With Urban Employee Basic Medical Insurance

    Nov 1, 2015, 00:00

  • Malaria Diagnosis And Treatment Practice Following Introduction of Rapid Diagnostic Test In Selected Health Posts of Adama Woreda, East Shewa Zone, Oromia Region,Centeral Ethiopia

    Nov 1, 2015, 00:00

  • Aretaeus- Retrospective Study Of Medication Usage Patterns Following The Diagnosis Of Type 2 Diabetes In Latin America

    Nov 1, 2015, 00:00

  • Quality of Life in Patients After Total Hip Replacement

    Nov 1, 2015, 00:00

  • Impact of Adherence to Oral Antidiabetics on All-Cause Mortality- A Population Based Study

    Nov 1, 2015, 00:00

  • Benefits And Risks of Vildagliptin/Metformin Versus Sulphonylureas/Metformin Combination Therapy In Type 2 Diabetes Mellitus (T2dm) From Patient’s Perspective- Real-World Data

    Nov 1, 2015, 00:00

  • Configuracion Espacial de La Vulnerabilidad Social de Inmigrantes Internacionales en Iquique 2002-2012 y Su Relacion Con La Localizacion de Red de Atencion Primaria de Salud

    Nov 1, 2015, 00:00

  • Medical Devices – Brest Forms. Cost And Quantity Characteristics Of Medical Devices In Slovakia 2009 – 2013

    Nov 1, 2015, 00:00

  • Healthcare Expenditure On Prevention In The Spending Review Era

    Nov 1, 2015, 00:00

  • Evaluation of Average Cost-Effectiveness Ratios of Standards of Care Across Different Indications

    Nov 1, 2015, 00:00

  • The Ups And Downs Of Hpv-Related Cancers- Trends 2005-2014

    Nov 1, 2015, 00:00

  • Costo - efectividad de la combinacion de glicopirronio/indacaterol vs. Salmeterol/ fluticasona (combinacion de dosis fija – cdf) en el manejo de los pacientes con enfermedad pulmonar obstructiva cronica (epoc) en colombia (sur américa)

    Nov 1, 2015, 00:00

  • Capturing Accurate Concomittant Medications Information in Global Trials

    Nov 1, 2015, 00:00

  • Impact of Alexithymia and Disease Characteristics on Work Productivity and Activity In Psoriasis Patients With Short Disease Duration- Epidepso Multicentre Study

    Nov 1, 2015, 00:00

  • The Research on The Incidence of Kashin-Beck Disease and The Selenium Level In Children of Xunyi County

    Nov 1, 2015, 00:00

  • High-Dose Inactivated Influenza Vaccine can Reduce Costs and Improve Outcomes Compared to Standard-Dose Inactivated Influenza Vaccine in Canadian Seniors

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Edoxaban Compared With Other Licensed Noacs For The Prevention Of Stroke And Systemic Embolic Events In The Uk

    Nov 1, 2015, 00:00

  • Aspirin Versus Clopidogrel in Patients with Ischemic Stroke- a Cost and Effectiveness Comparison from Beijing Medical Insurance Database

    Nov 1, 2015, 00:00

  • Análisis De Costo Efectividad Y Costo Utilidad De La Adición De Rivaroxabán En El Tratamiento De Pacientes Con Síndrome Coronario Agudo En Colombia

    Nov 1, 2015, 00:00

  • Does One Size Fit All? - Challenges Faced when Adapting Translations for an Electronic Platform

    Nov 1, 2015, 00:00

  • Comparison of Regulatory Labels And Hta Decisions for Chronic Hepatitis-C Therapies

    Nov 1, 2015, 00:00

  • Efficacy-Effectiveness-Gap – Extent, Causes And Implications

    Nov 1, 2015, 00:00

  • Local Cost Study Of Treatment Of Venous Thromboembolism In Turkey

    Nov 1, 2015, 00:00

  • Aligning Patient Centred Evidence Generation Across the Drug Development Lifecycle

    Nov 1, 2015, 00:00

  • Fixed Combination Netupitant And Palonosetron Is A Cost-Effective Intervention For The Prevention Of Chemotherapy-Induced Nausea And Vomiting In The Uk

    Nov 1, 2015, 00:00

  • Tabagismo Em Universitários- Uma Revisão Sistemática Da Literatura

    Nov 1, 2015, 00:00

  • Cost Effectiveness of Rifaximin-Á 550mg In The Reduction of Recurrence of Overt Hepatic Encephalopathy In United Kingdom

    Nov 1, 2015, 00:00

  • The Association of Waist Circumference with Glycaemic Control in Diabetic Patients in an Asian Population

    Nov 1, 2015, 00:00

  • Effect of Patient-Education on Health-Related Quality of Life of Diabetic Foot Ulcer Patients In A Tertiarycare Hospital

    Nov 1, 2015, 00:00

  • Pricing and Reimbursement Policies of Turkey and Ukraine

    Nov 1, 2015, 00:00

  • Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients?

    Nov 1, 2015, 00:00

  • Social Utility Values for Pemphigus Vulgaris and Foliaceus- A Composite Time Trade-Off Study

    Nov 1, 2015, 00:00

  • Budget Impact Analysis Of Phased Radiofrequency (Rf) Catheter Ablation System In The Treatment Of Atrial Fibrillation (Af) In Turkey

    Nov 1, 2015, 00:00

  • Network Meta-Analysis of Various Treatment Strategies in Resistant Hypertension

    Nov 1, 2015, 00:00

  • Study on Cost-Effectiveness Analysis for Treatment of Major Depression Disease- a Systematic Review of Literature From 2004-2014

    Nov 1, 2015, 00:00

  • Eficacia Y Seguridad Del Uso Del Cetuximab En Pacientes Con Cancer Colorrectal Metastásico

    Nov 1, 2015, 00:00

  • Economic Evaluation of Chondroitin Sulfate and Non-Steroidal Antiinflammatory Drugs for The Treatment of Osteoarthritis

    Nov 1, 2015, 00:00

  • A Simulation Analysis Using The Orange Price Reference Tool

    Nov 1, 2015, 00:00

  • Evaluating the Cost-Effectiveness of GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the UK

    Nov 1, 2015, 00:00

  • The Survey of Physicians’ Satisfaction of Implementing Interventions for Changing Prescribing Behavior Toward Rational Medicine Use-2014

    Nov 1, 2015, 00:00

  • Number of Osteoporosis Patients with Pathological Fractures By Gender in Outpatient Care in the Light of Physiotherapy Care in Hungary

    Nov 1, 2015, 00:00

  • An Assessment of The Hospitalization Costs of Melanoma in France in the Advanced/Metastatic Setting- the Melissa Study (Melanoma in Hospital Costs Assessment)

    Nov 1, 2015, 00:00

  • Knowledge And Awareness Of Breast Cancer Among Young Women Living In South India

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Apremilast for The Treatment of Moderate to Severe Psoriasis In Spain

    Nov 1, 2015, 00:00

  • Health Technological Supports to Detect Medication Errors- The Saniarp Case-Study

    Nov 1, 2015, 00:00

  • Relationship of Time in Therapeutic Range (Ttr) with Bleeding and Stroke Incidences of Warfarinised Patients with Pulmonary Embolism in a Tertiary Hospital in Malaysia

    Nov 1, 2015, 00:00

  • The Cost-Effectiveness of Referring Patients With Irritable Bowel Syndrome To A Gastroenterologist In The Uk

    Nov 1, 2015, 00:00

  • Scoping Review of Publicly Available Performance Information in Argentina, Chile and Colombia

    Nov 1, 2015, 00:00

  • Study Of Acute Lower Respiratory Tract Infections In Children Of Age Group 1 Month To 5 Years

    Nov 1, 2015, 00:00

  • Patient Perspective on Convenience and Intensification of Insulin Treatment In Type 2 Diabetes In Italy

    Nov 1, 2015, 00:00

  • A Mixed Methods Study of Researchers’ Experiences of Developing Core Outcome Sets

    Nov 1, 2015, 00:00

  • Benchmarking Health Technology Assessment (Hta) Agencies for Setting Standards on Pharmacoeconomic, Pricing, Evidence, and General Submission Requirements- development of a Multidimensional Rating Scale

    Nov 1, 2015, 00:00

  • Medical Devices- Innovative Models To Access The Market Leveraging On Shared Infrastructure Among Payers And Pharmaceutical Companies

    Nov 1, 2015, 00:00

  • 5th LAC Abstracts FDS and 18th Euro Abstracts FDS - Financial Disclosure

    Nov 1, 2015, 00:00

  • Incremental Quality Adjusted Life Years (Qaly) Analysis in Absence of Head to Head and Health Related Quality of Life (Hrqol) Data- a Case Study in Thyroid Cancer

    Nov 1, 2015, 00:00

  • Assessing the Cost-Effectiveness of Antiretroviral Treatments in Hiv- an Individual Patient Simulation Approach

    Nov 1, 2015, 00:00

  • High-Cost Oncologic Medication Access- Why Is Latin America Falling Behind? Case Study In Non-Small Cell Lung Cancer (NSCLC)

    Nov 1, 2015, 00:00

  • Convergent Validity of New Disease Assessment Instruments (Dai) In Systemic Lupus Erythematosus (Sle) In Relation to Sledai-2k

    Nov 1, 2015, 00:00

  • Impact of Nurse-Led Telecoaching on the Annual Healthcare Utilization and Costs in People with Type 2 Diabetes in Belgium. Within-Trial Analysis of Health Insurance Data

    Nov 1, 2015, 00:00

  • Modelled U.K. And U.S. Analyses Demonstrate Sherlock 3cg® Tip Confirmation System For Peripherally Inserted Central Catheter Placement Is Associated With Favourable Health Economic Outcomes

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Romiplostim for The Treatment of Adult Chronic Immune Thrombocytopenic Purpura (Itp) In Brazil

    Nov 1, 2015, 00:00

  • The Medical Technologies Evaluation Programme (Mtep)- An Analysis Of Notifications, Decision-Making And The Interpretation Of Claimed Healthcare System Benefits

    Nov 1, 2015, 00:00

  • A Pharmacoeconomic Analysis of Costs From The Tumor Bank of The Instituto Nacional De Cancerologia Mexico

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of New Therapies for Multiple Sclerosis In Spain

    Nov 1, 2015, 00:00

  • Resource Use And Direct Costs For Managing Hcv Genotype 1 Patients In Colombia

    Nov 1, 2015, 00:00

  • Assessing The Esmo Magnitude of Clinical Benefit Scale From A Health Economics Perspective

    Nov 1, 2015, 00:00

  • Cost Offset Analysis of Interferon Beta Disease Modifying Therapies In Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2015, 00:00

  • Have Infliximab Discounted Prices in Norway Had an Impact on Prices Around the World?

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Exenatide Once-Weekly Versus Dulaglutide, Liraglutide and Lixisenatide for the Treatment of Type 2 Diabetes Mellitus- An Analysis from the UK NHS Perspective

    Nov 1, 2015, 00:00

  • The Cost of Rehumatoid Diseases In Italy- Analysis From An Italian Administrative Database

    Nov 1, 2015, 00:00

  • Budget-Impact-Analysis Of Iron Treatment Using Intravenous Ferric Carboxymaltose In Patients With Chronic Heart Failure And Iron Deficiency In Austria

    Nov 1, 2015, 00:00

  • Hllkj

    Nov 1, 2015, 00:00

  • Influence of Some Factors on The Morphological Structure of Spermatozoa In Straight Intestine During Forensic - Medical Examination of Sodomy

    Nov 1, 2015, 00:00

  • Iron Deficiency In Patients With Chronic Heart Failure- A Systematic Literature Review

    Nov 1, 2015, 00:00

  • Biosimilar Trials- Patient Recruitment and Barriers in Brazil

    Nov 1, 2015, 00:00

  • Applying Karnofsky Performance Scale In Hospitalized Patients For Promoting Rational Therapy

    Nov 1, 2015, 00:00

  • Resistência Antimicrobiana- Identificação Das Pesquisas Brasileiras Fomentadas Para Suporte À Gestão No País

    Nov 1, 2015, 00:00

  • An Assessment of Annual Costs of Patients Hospitalized for Spinal Tumors in Fran Analysis Using the Pmsi Database

    Nov 1, 2015, 00:00

  • Clinical And Economic Benefits Associated With Less Use Of Fluticasone In Pediatric Patients With Persistent Asthma Treated With High Doses Of Specific Allergen Immunotherapy To Mites

    Nov 1, 2015, 00:00

  • The Assessment Of Value For Medical Devices- A Case Study On Injection Technique Education In Insulin Delivery

    Nov 1, 2015, 00:00

  • Study On Cost-Effectiveness Analysis For Multiple Myeloma Treatment- A Systematic Review Of Literature From 2004-2014

    Nov 1, 2015, 00:00

  • Treatment Patterns And Budgetary Impact of Chemotherapy Drugs In A Brazilian Private Health Plan (Php)

    Nov 1, 2015, 00:00

  • Cost of Questionnaire-Based Process to Identify Occupational Exposures Among Patients with Lung Cancer

    Nov 1, 2015, 00:00

  • Health States Worse Than Dead In An Elderly Population – Prevalence and The Significance of Chronic Pain

    Nov 1, 2015, 00:00

  • Assessing The Potential for Tiered Pricing of High Priced Therapies Within Argentina, Columbia, Mexico, Indonesia, and Thailand

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Trimetazidine In The Management Of Chronic Stable Angina In Greece

    Nov 1, 2015, 00:00

  • Reforming The Reformed - Hospital Pharmaceutical Expenditure In Greece Over The Crisis Era; Looking At What Has Been Achieved When Planning Ahead

    Nov 1, 2015, 00:00

  • Intravitrael Aflibercept Injection for The Treatment of Visual Impairment Due to Macular Oedema Secondary to Branch Retinal Vein Occlusion- Cost-Effectiveness Versus Ranibizumab

    Nov 1, 2015, 00:00

  • Do Socioeconomic Inequalities Impact The Social Cost Of Chronic Kidney Disease In Italy?

    Nov 1, 2015, 00:00

  • Analysis Of Stroke Statistics In Turkey

    Nov 1, 2015, 00:00

  • Sugar Free Gum In The Prevention of Caries- A Comparison of Germany and Finland

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Continuous Infusion Pump With Integrated Monitoring Compared With Multiple Daily Injection Treatment for Patients 15-Years or Older With Type 1 Diabetes Mellitus In Colombia

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Transcatheter Aortic Valve Replacement- Current Decision-Analytic Models and Future Opportunities

    Nov 1, 2015, 00:00

  • Autosomal Polycystic Kidney Disease (Adpkd)- Costs And Resource Utilisation In The Nordic Countries

    Nov 1, 2015, 00:00

  • Desarrollo de Una Guia de Intervencion Psicologica Para Artritis Reumatoide en Colombia

    Nov 1, 2015, 00:00

  • The Effectiveness of Cbl Gene Mutation Test for Diagnosis In Juvenile Myelomonocytic Leukemia- Systematic Reviews

    Nov 1, 2015, 00:00

  • Comparative Effectiveness of Triple Antihypertensive Combination Therapy for Patients with Resistant Hypertension In Taiwan

    Nov 1, 2015, 00:00

  • Improved Survival In Patients With Advanced Melanoma In Real-World Clinical Practi First Results Of The Dutch Melanoma Treatment Registry

    Nov 1, 2015, 00:00

  • Impact of Major Changes To The Brazilian Health Care System Utilizing The Heat Maps Project

    Nov 1, 2015, 00:00

  • The Cost-Effectiveness of Canagliflozin (CANA) Versus Dapagliflozin (Dapa) 10mg and Empagliflozin (EMPA) 25mg in Patients with Type 2 Diabetes Mellitus (T2DM) as Monotherapy in the United Kingdom

    Nov 1, 2015, 00:00

  • Generalized Implementation of Em Algorithm for Estimation of Transition Probability Matrix

    Nov 1, 2015, 00:00

  • Health-Economic Evaluation of Clostridium Difficile Infection (Cdi) And Epidemiology In England And Merseyside

    Nov 1, 2015, 00:00

  • All Qalys Are Equal, But Some Qalys Are More Equal Than Others; A Comparison Of The Nice End Of Life Criteria And Smc Pace Process

    Nov 1, 2015, 00:00

  • Impact of Poverty on Multidimensional Infant Mortality Rate In Brazil

    Nov 1, 2015, 00:00

  • The Burden of Moderate-To-Severe Irritable Bowel Syndrome With Constipation (Ibs-C) In Fran A Comparison With The European Results From The Ibis-C Observational Study

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Oral Anticoagulation Therapies (Oat) In China

    Nov 1, 2015, 00:00

  • Resource Use And Costs of Congestive Heart Failure Hospitalizations- A Retrospective Cohort Study In Argentina

    Nov 1, 2015, 00:00

  • The Opportunities Of Internet Technology And Telemedicine In Interaction Between Doctor And Patient

    Nov 1, 2015, 00:00

  • Contrasting Predictions of Cardiovascular Incidence Derived From Alternative Risk Prediction Models In Type 1 Diabetes

    Nov 1, 2015, 00:00

  • Comparison Of Comorbidity Measures To Predict Economic Outcomes In A Large Uk Primary Care Database

    Nov 1, 2015, 00:00

  • Cost Effectiveness Analysis of Aripiprazole Once-Monthly Versus Paliperidone Palmitate in Spain

    Nov 1, 2015, 00:00

  • Comparing Resource Use In Alzheimer’s Disease Across Three European Countries - 18-Month Results of The Geras Study

    Nov 1, 2015, 00:00

  • Simulating Individual Patient Level Data Using An Illness-Death Modelling Framework In Order to Adjust for Treatment Switching When Only Summary Data Are Available

    Nov 1, 2015, 00:00

  • Determinação do Impacto Orçamentário no Modelo de Pagamento de Medicamentos Em Uma Operadora de Planos de Saúde- Buscando Novas Estratégias Para Minimizar Os Custos

    Nov 1, 2015, 00:00

  • Budget Impact Analysis Of Formoterol Easyhaler In The Treatment Of Asthma In Children In The Russian Federation

    Nov 1, 2015, 00:00

  • Survival and Rehospitalization After a First Hospitalization for Heart Failure- a Nationwide Population-Based Cohort Study using the French Egb Database

    Nov 1, 2015, 00:00

  • Timed Automata Modeling of The Personalized Treatment Decisions In Metastatic Castration Resistant Prostate Cancer

    Nov 1, 2015, 00:00

  • Economic Evaluation Of A Pharmacogenomic Test For Statin-Induced Myopathy In Cardiovascular High-Risk Patients Initiating A Statin

    Nov 1, 2015, 00:00

  • Coping With Discrepancies In Epidemiological Data From Various Sources For Low-Incidence Diseases- The Case Of Multidrug-Resistant Tuberculosis In Germany

    Nov 1, 2015, 00:00

  • Application Of Asco Value Framework Evaluations Of Net Health Benefit For Oncology Drugs Launched In The United States Between 2013 And 2015

    Nov 1, 2015, 00:00

  • A Next-Generation Framework- Deciding On The Role Of Costs In The Clinical Use Of Targeted Gene Panels, Exome And Genome Sequencing

    Nov 1, 2015, 00:00

  • Factores Pronosticos De Sobrevida En La Neoplasia Trofoblastica Gestacional

    Nov 1, 2015, 00:00

  • Treatment Patterns and Characteristics of Medicare Beneficiaries with Hiv Related Cachexia

    Nov 1, 2015, 00:00

  • A Systematic Literature Review of Risk Prediction Models for Mortality, Complications and Diabetes Outcomes After Bariatric Surgery

    Nov 1, 2015, 00:00

  • The Nationwide Osmed Health-Db Database. A Tool To Support Healthcare Decision-Making And Real-World Evidence Generation

    Nov 1, 2015, 00:00

  • Pharmacovigilance Of Anti-Neoplastic Agents In A Developing Country—A Report Through A Spontaneous Reporting Contineous Monitoring System

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Delayed-Release Dimethyl Fumarate for The Treatment of Relapsing Remitting Multiple Sclerosis In Spain

    Nov 1, 2015, 00:00

  • Cost of Early Retirement Caused By Rheumatic Diseases In Portugal

    Nov 1, 2015, 00:00

  • The Actual Cost of a “Forced Switch” of Psychiatric Patients to a New Therapy- a Markov Chain – Monte Carlo Simulation

    Nov 1, 2015, 00:00

  • Disease Burden And Costs Associated With Urinary Tract Infections In Type 2 Diabetes Mellitus Patients- An Analysis Based On A Large Sample Of 456,586 German Patients

    Nov 1, 2015, 00:00

  • Analysis of the Relationship Between Patient-Reported Outcomes (Pros) and Clinical Outcomes In Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Patients without Prior Chemotherapy

    Nov 1, 2015, 00:00

  • The Effectiveness Of Wide Field Fluorescein Angiography - Systematic Reviews

    Nov 1, 2015, 00:00

  • Policy Implications of Affordable Care Act on Us Market Access

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Incobotulinumtoxin-A With Flexible Treatment Intervals Compared to Onabotulinumtoxin-A In The Management of Blepharospasm And Cervical Dystonia

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis Of Chocolate Consumption For Prevention Of Cardiometabolic Disease

    Nov 1, 2015, 00:00

  • Hiv Patient Preferences for Simplified Treatment Regimens

    Nov 1, 2015, 00:00

  • Meses Evitados De Diálisis En Una Poblaci”N Con Enfermedad Renal Cr”Nica Estadio 5 Con Intervenci”N Predialítica En Colombia

    Nov 1, 2015, 00:00

  • Valuation of Patient Satisfaction With Pharmaceutical Care As A Tool For Increasing Quality Management In Community Pharmacy And Patient’s Quality Of Life

    Nov 1, 2015, 00:00

  • The Cost Of Treatment Of The New Antiviral Therapies Against The Hepatitis C Virus

    Nov 1, 2015, 00:00

  • Cost-Savings And Cost-Utility Of An Ehr System Smartphone App In A Trauma Intensive Care Unit

    Nov 1, 2015, 00:00

  • Investigating The Impact of Structural Changes In A Nice Single Technology Appraisal Cost-Effectiveness Model

    Nov 1, 2015, 00:00

  • Cost-Utility of Omalizumab Compared With Standard of Care for The Treatment of Chronic Spontaneous Urticaria (Csu)

    Nov 1, 2015, 00:00

  • Evaluation Of Patterns Of Care In Renal Cell Carcinoma (Rcc)- High Unmet Need Persists

    Nov 1, 2015, 00:00

  • Performance of Drg-Based Reimbursement Policy In National Health Insurance - Eight Years’ Experiences

    Nov 1, 2015, 00:00

  • Clinical Pathway And Health Care Resources Utilization Of A Patients Cohort At High Risk Of Cardiovascular Disease Of Local Healthcare Unit (Asln°1) Of Milan- A Results Of Intervention On Secondary Prevention

    Nov 1, 2015, 00:00

  • Efficacy of The Mica Antibody for Transplant Patients

    Nov 1, 2015, 00:00

  • Real-World Evidence of Iron Chelation Therapy In Transfusion-Dependent Mds Patients- A Portuguese Hospital Registry

    Nov 1, 2015, 00:00

  • Cost Effectiveness of Triple Therapy for Adults Patients with Genotype 1 Chronic Hepatitis C

    Nov 1, 2015, 00:00

  • Costo-Efectividad De La Cuantificaci”N De La Actividad Enzimática En Leucocitos En Comparaci”N A Su No Realizaci”N Para La Confirmaci”N Diagn”Stica De La Mucopolisacaridosis Tipo Iva En Colombia

    Nov 1, 2015, 00:00

  • The Cost Of Nutrition Alternatives For Premature Infants In The Neonatal Intensive Care Unit In Russia

    Nov 1, 2015, 00:00

  • Cost-Minimization Analysis Of Rivaroxaban In Comparison To Enoxaparin Plus Warfarin For The Treatment Of Venous Thromboembolism (Vte) Under The Private Healthcare System Perspective

    Nov 1, 2015, 00:00

  • Physicians’ Prescribing Pattern For Tuberculosis- Evidences From Community Pharmacies In Punjab, Pakistan

    Nov 1, 2015, 00:00

  • Effectiveness of A Referral Program for Early Arthritis Diagnosis At Primary Care Centers in Portugal - Preliminary Results from the Siara Study

    Nov 1, 2015, 00:00

  • An Analysis of Diabetic Medicine Utilization In Turkey

    Nov 1, 2015, 00:00

  • Treatment of Macular Edema- What’s New? Evidence From An Hta Study Comparing Ranibizumab And Dexamethasone Implant

    Nov 1, 2015, 00:00

  • Health Care Coverage Through Private Health Insurance

    Nov 1, 2015, 00:00

  • The Cost-Effectiveness Of Regorafenib In The Treatment Of Metastatic/Inoperable Gastrointestinal Stromal Tumors In Turkey

    Nov 1, 2015, 00:00

  • Evolution of Treatment Paradigms In Metastatic Castrate-Resistant Prostate Cancer

    Nov 1, 2015, 00:00

  • Impacto Económico Del Uso De Vismodegib En El Tratamiento De Pacientes Con Carcinoma Basocelular Localmente Avanzado En Venezuela

    Nov 1, 2015, 00:00

  • A Microcosting Study Of Radiation Therapy In Localized Prostate Cancer Patients In A Hungarian Tertiary Oncology Center

    Nov 1, 2015, 00:00

  • Health-Economic Comparison of a Gnrh-Antagonist (Degarelix) Vs. Gnrh-Agonists Considering the Number-Needed-to-Treat to Avoid Cardiovascular Events

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Implementing Tenders Between The Branded Infliximab And Its Biosimilars In The Public Hospitals of Paris

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis Of Novel Oral Anticoagulants For Acute Treatment And Secondary Prevention Of Venous Thromboembolic Disease

    Nov 1, 2015, 00:00

  • When “Alive After 5 Years” Does Not Mean “Cured”- International Patterns In Cancer 10- To 20- Year Relative Survival Rates

    Nov 1, 2015, 00:00

  • Economic Analysis Of Evarrest® Sealant Matrix Compared With Standard Of Care In Severe Soft Tissue Surgical Bleeding- An Italian Hospital Perspective

    Nov 1, 2015, 00:00

  • Costs Associated With Patients Diagnosed With Relapsing Remitting Multiple Sclerosis Taking Once Daily Fingolimod Capsules In The United States

    Nov 1, 2015, 00:00

  • Revisiting The Simulation Evidence for the Incremental Cost-Effectiveness of Breast Cancer Screening of Average-Risk Women

    Nov 1, 2015, 00:00

  • Cost-effectiveness of Ranibizumab Vs. Dexamethasone Implant In Diabetic Macular Edema

    Nov 1, 2015, 00:00

  • Impact Of A Novel Ibs Diagnostic Blood Panel For Mexico- Cost Implications To The Mexican Private Practice For Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D)

    Nov 1, 2015, 00:00

  • Differences Between The Efficacy of Biosimilars and Originators - Analysis and Implications for The Cost-Effectiveness-Analysis From A Payers Perspective

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis Of Everolimus Immunosupressive Therapy After Renal Transplantation

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Ponatinib In The Treatment of Chronic-Phase Chronic Myeloid Leukemia (Cp-Cml) In Sweden

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Introducing Lisdexamfetamine Dimesylate for the Treatment of Binge Eating Disorder in the United States

    Nov 1, 2015, 00:00

  • Costo-Utilidad de Un Esquema Inicial de Tratamiento Con Tofacitinib Comparado Con Terapia Biologica Anti-Tnf en Pacientes Adultos Con Artritis Reumatoide Que Han Presentado Respuesta Inadecuada a Metotrexato en Venezuela

    Nov 1, 2015, 00:00

  • Population Cost-Effectiveness of a Parenting Program for the Treatment of Conduct Disorders- a Modelling Study to Assist Priority Setting in Australia

    Nov 1, 2015, 00:00

  • Health Care Costs Associated With Geriatric Patients Diagnosed With Multiple Sclerosis Taking Disease Modifying Agents In The United States

    Nov 1, 2015, 00:00

  • Adherence With Therapeutic Guidelines In The Treatment Of Venous Thromboembolism And Pulmonary Embolism In Clinical Practice. Findings From The Victor Study

    Nov 1, 2015, 00:00

  • Effect of Persistence of Biologic Therapy on Long Term Direct Healthcare Costs of Psoriatic Arthritis In Russian Plaque Psoriasis Patients

    Nov 1, 2015, 00:00

  • Review of Policies And Perspectives on Real-World Data for Drug Development and Assessment (Imi-Getreal Deliverable)

    Nov 1, 2015, 00:00

  • Value Assessment and Pricing Frameworks for Rare Disease Treatments- New Approaches From The Literature

    Nov 1, 2015, 00:00

  • Geographical Disparities in Colon Cancer Care in Europe- Implications for Access to Innovative Medicines Via the UK Cancer Drugs Fund

    Nov 1, 2015, 00:00

  • Reversal of Neuromuscular Blockade- A Discrete Event Simulation Model of Clinical and Operating Room Efficiency Outcomes of Sugammadex Versus Neostigmine In Canada

    Nov 1, 2015, 00:00

  • The Clinical and Economic Burden of Medication Errors In The Canadian Acute Care Setting- A Review of Published Studies

    Nov 1, 2015, 00:00

  • Re-Use Of Insulin Syringe Needles And Its Extra Disease Burden For Diabetic Patients In Beijing

    Nov 1, 2015, 00:00

  • Validation of the English Version of the Forgotten Joint Score - 12 in Patients Undergoing Total Knee or Hip Arthroplasty

    Nov 1, 2015, 00:00

  • Pharmacy Cost Differences Associated with the Initiation of Exenatide Once-Weekly Compared to Liraglutide Once-Daily

    Nov 1, 2015, 00:00

  • Retrospective Comparison Of Real-Life Survival Data From Single Centre Trials - The Clinical Outcome Of Vemurafenib Therapy In Metastatic Melanoma Patients

    Nov 1, 2015, 00:00

  • Equity in Access to High Cost Drugs in Uruguay

    Nov 1, 2015, 00:00

  • Patterns Of Use Of Tests To Monitor Disease Activity Among Patients Currently Treated For Relapsing Remitting Multiple Sclerosis (Rrms) In Europe

    Nov 1, 2015, 00:00

  • Estimating the Monetary Value of Relief of Tennis Elbow- A Contingent Valuation Study of Willingness-To-Pay

    Nov 1, 2015, 00:00

  • Comparison of Economic Evaluation Between Three Major HTA Agencies. Is There a French Touch?

    Nov 1, 2015, 00:00

  • Hematological Toxicities Associated with Pazopanib use in Cancer Patients- A Meta-Analysis

    Nov 1, 2015, 00:00

  • Estimating Seasonal Allergic Conjunctivitis Market Size And Spending

    Nov 1, 2015, 00:00

  • Economic Burdens of the Top 10 Cancers During 2003-2012 in Taiwan

    Nov 1, 2015, 00:00

  • Examining The Sociological Influences on Physician Prescribing Behavior of Type 2 Diabetic Medications In Us Outpatient Setting

    Nov 1, 2015, 00:00

  • Acromegaly Patients with Inadequate Response to Maximum Dose Octreotide-Lar Who Progress to Treatment with Pegvisomant- Economic Evaluation and Incremental Budget Impact Analysis from the Public Perspective to São Paulo State

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis of Different Strategies of Replacement Therapy In Russian Patients With Pancreatic Exocrine Insufficiency

    Nov 1, 2015, 00:00

  • Evaluation of Inhaler Technique Mastery and Handling Errors With Spiromax®, Easyhaler®, And Turbuhaler® Devices (Finhaler)

    Nov 1, 2015, 00:00

  • Analysis of The Consumption And Pharmacoeconomic Evaluation of Using Different Formulations of Alpha-Lipoic Acid In The Pharmaceutical Market of Ukraine

    Nov 1, 2015, 00:00

  • A Scotland Based Cost-Effectiveness Analysis Of Idelalisib (Zydelig®) In Combination With Rituximab For The Treatment Of Adults With Chronic Lymphocytic Leukaemia Cll)

    Nov 1, 2015, 00:00

  • Does China’s New Medical Reform Improve Health Equity Of Rural Residents? Evidence From Household Surveys Before And After The Implementation Of New Medical Reform In Shaanxi Province, China

    Nov 1, 2015, 00:00

  • Making Collaborative Relative Effectiveness Assessments Relevant- Experience of 4 Eunethta Pilots Across Pharmaceuticals and Medical Devices

    Nov 1, 2015, 00:00

  • How to Model Survival In Cost-Effectiveness Analysis? Differences Between Markov and Partitioned Survival Analysis Models

    Nov 1, 2015, 00:00

  • Stimulant Use and Cardiovascular Risk Among Children And Adolescents With Adhd- What Product Labeling Does, or Does Not, Tell Us

    Nov 1, 2015, 00:00

  • Examining the Economic Burden and Health Care Utilization of Menopausal Women in the U.S. Medicaid Population

    Nov 1, 2015, 00:00

  • Assessment of Iron Deficiency And Anemia In Pregnant Women In Fran An Observational Study

    Nov 1, 2015, 00:00

  • The Economic Impact Of Shape Formula For The Children Of Overweight And Obese Mothers

    Nov 1, 2015, 00:00

  • UNDERSTANDING THE RELATIONSHIP BETWEEN HEALTH ASSESSMENT QUESTIONNAIRE-DISABILITY INDEX (HAQ-DI), PSORIASIS AREA SEVERITY INDEX (PASI), AND QUALITY OF LIFE (QOL) AND ITS INFLUENCE ON COST-EFFECTIVENESS IN PSORIATIC ARTHRITIS (PSA)

    Nov 1, 2015, 00:00

  • Real-World Treatment Patterns of Ranibizumab Among Patients With Retinal Diseases In Canada- 5 Years Of Data

    Nov 1, 2015, 00:00

  • Costs Of Cardiovascular (Cv) Events In The United Kingdom (Uk) Using Real-World Data

    Nov 1, 2015, 00:00

  • Health State Utilities for Gaucher Disease Type 1

    Nov 1, 2015, 00:00

  • Atc1 Group Discount Distribution Analysis of Original Medicines Which Has No Generics In Turkey

    Nov 1, 2015, 00:00

  • Exploring the Use of Value of Information Methods to Prioritise Research to Address the Treatment Uncertainties Identified By the James Lind Alliance Priority Setting Partnerships

    Nov 1, 2015, 00:00

  • A Network Meta-Analysis (NMA) to Assess the Longer-Term Relative Efficacy of Canagliflozin in Patients with Type 2 Diabetes Inadequately Controlled on Metformin

    Nov 1, 2015, 00:00

  • Burden Of Infantile Hemangioma On Family- An International Cross-Sectional Study

    Nov 1, 2015, 00:00

  • Adverse Drug Reactions, Medication Adherence and Physicians’ Prescribing Behavior- Which Relationship? a Database Analysis on Statin use

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis Of The Combined Homocysteine-Lowering And Standard Therapy Versus Standard Therapy Of Patients With Chd, Postpercutaneous Coronary Intervention (Pci) And B12 Deficiency

    Nov 1, 2015, 00:00

  • Development of Hospital-Based Hta Unit Processes In The Czech Hospital Environment

    Nov 1, 2015, 00:00

  • Cost of Reaching Defined HbA1c Target Using Canagliflozin Compared to Dapagliflozin as Add-On to Metformin in Patients with Type 2 Diabetes Mellitus (T2DM) in the United Arab Emirates (UAE)

    Nov 1, 2015, 00:00

  • Device Inhalators In Asthma and Their Impact on Treatment Adherence

    Nov 1, 2015, 00:00

  • Screening Guidelines And Cancer Stage- Early Findings From Medicare

    Nov 1, 2015, 00:00

  • Costs for Diabetic Patients Receiving Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in US Medicare and Commercial Insurance Plans

    Nov 1, 2015, 00:00

  • Biosimilars Entry And Price Development In Europe

    Nov 1, 2015, 00:00

  • Prediction Model for Functional Status at Discharge Following Rhabilitation After Intracerebral Hemorrhage

    Nov 1, 2015, 00:00

  • Quality Of Life In Women Patients With Urinary Incontinence In Slovakia

    Nov 1, 2015, 00:00

  • Longitudinal Modeling Of The Relationship Between Lisdexamfetamine Dimesylate And Health-Related Quality Of Life In Adults With Moderate To Severe Binge Eating Disorder

    Nov 1, 2015, 00:00

  • Impact of a Pharmacotherapeutic Follow-Up Program on the Cost-Month-Patient, Stratified By Risk-Pharmacological Type

    Nov 1, 2015, 00:00

  • Italian Healthcare Expenditure Trends From 2002 To 2013

    Nov 1, 2015, 00:00

  • The Value of Achieving Complete or Near Complete Resolution of Psoriasis

    Nov 1, 2015, 00:00

  • Economic Analysis Of Evicel® Compared With Standard Of Care For Dural Closure In Elective Cranial Surgery- A United Kingdom Hospital Perspective

    Nov 1, 2015, 00:00

  • The Use and Acceptance of Meta-Analysis of Survival Outcomes to Support Health Technology Assessment Submissions in the Uk

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Tobacco Dependence Treatment In The Czech Republic

    Nov 1, 2015, 00:00

  • General Assessment Of Unlicensed Medicine Usage In Turkey

    Nov 1, 2015, 00:00

  • Rapid and Automated Test for Connectedness of Evidence Networks in Network Meta Analysis

    Nov 1, 2015, 00:00

  • Cardiovascular Outcomes of Antidiabetic Therapy - Results of a Literature Search

    Nov 1, 2015, 00:00

  • Hunting For Randomised Controlled Trials (Rcts)- A Comparison Of Search Filters Designed To Identify Rcts

    Nov 1, 2015, 00:00

  • Impact Of Her2 Testing Quality Improvement From A Health Economic Perspective

    Nov 1, 2015, 00:00

  • Is Assignment of Financial Value Stimulating French Researchers of Paris Academic Hospitals to Publish in International Journals? Results of the Diazepam Survey

    Nov 1, 2015, 00:00

  • External Validity of the Well-Being Related to Food Questionnaire (Well-Bfq©)- Variations According to the Subjects’ Nutritional Status

    Nov 1, 2015, 00:00

  • A Method Based on the Remaining Value of Perfect Information for the Sample Size Calculation in Randomized Trial-Based Cost-Effectiveness Analyses

    Nov 1, 2015, 00:00

  • Prescription Pattern of Outpatient Department of A Teaching Hospital Quetta, Pakistan

    Nov 1, 2015, 00:00

  • Antibiotic Prescription Practices of Pediatricians In Hospital Care In Cyprus

    Nov 1, 2015, 00:00

  • Characteristics of Patients With Relapsing Remitting Multiple Sclerosis Taking Once Daily Fingolimod Capsules In The United States

    Nov 1, 2015, 00:00

  • The Cost-Effectiveness Analysis of Philips Motiva Telehealth System- A Comparison Between Home Telemonitoring, Nurse Telephone Support And Usual Care In Chronic Heart Failure

    Nov 1, 2015, 00:00

  • A One-Year Follow-Up of Individuals with Diabetes at Very High Cv Risk Treated With Statins- Outcomes and Health Care Costs

    Nov 1, 2015, 00:00

  • The Cost of Radiotherapy- What Do We Know? a Systematic Search of the Literature Between 1981 and 2015

    Nov 1, 2015, 00:00

  • Economic Value of Stemi Program Investment In Sao Paulo, Brazil

    Nov 1, 2015, 00:00

  • Role Of Pharmacoeconomic Analysis In Pricing Decision In Japan

    Nov 1, 2015, 00:00

  • Real-World Hepatitis C Treatment Strategies in Denmark

    Nov 1, 2015, 00:00

  • Avaliação Do Impacto Econômico De Afastamentos Laborais Por Câncer De Mama . Análise Preliminar Singular Institucional

    Nov 1, 2015, 00:00

  • Application of Simple Imputation Techniques for Missing Pairwise Contrasts from Multi-Arm Trials when Using Frequentist Network Meta Analysis

    Nov 1, 2015, 00:00

  • Cost Of Genome Analysis- The Sanger Sequencing Method

    Nov 1, 2015, 00:00

  • Pilot Assessment Of Pharmaceuticals Based On The Eunethta Core Model For Rapid Relative Effectiveness Assessment

    Nov 1, 2015, 00:00

  • Subcutaneous Vs Intravenous Administration Of Trastuzumab In Her2+ Breast Cancer Patients- A Macedonian Cost-Minimization Analysis

    Nov 1, 2015, 00:00

  • A Cost-Effective Analysis of The Optimum Number of Blood Culture for Adult Patients With Infection

    Nov 1, 2015, 00:00

  • Budget Impact Analysis Of Bioabsorbable Drug-Eluting Sinus Implants For Endoscopic Sinus Surgery

    Nov 1, 2015, 00:00

  • Development of an Eq-5d Respiratory Bolt-on

    Nov 1, 2015, 00:00

  • Patient-Reported Outcomes in Studies Published in 2014- Which Disease Areas Have Been the Main Focus of Clinical Research?

    Nov 1, 2015, 00:00

  • Risk Equation For Alcohol Related Consequences

    Nov 1, 2015, 00:00

  • The Indirect Costs of Multiple Sclerosis Associated With Absenteeism In Poland In 2013

    Nov 1, 2015, 00:00

  • Monitored Cognitive Debriefing Interviews- a Case Study

    Nov 1, 2015, 00:00

  • The Increasing Cost Burden of Obesity Related Cancer to Nhs England

    Nov 1, 2015, 00:00

  • The Potential Societal Cost Benefits Of Increasing Patient Satisfaction By Using An Inhaler With Improved Features Compared To Spiriva® Handihaler® For The Management Of Chronic Obstructive Pulmonary Disease (Copd) In The Uk

    Nov 1, 2015, 00:00

  • Validation Of The Overactive Bladder Questionnaire (Oab-Q; 1-Week Recall) In Medically Complex Elderly Adults With Overactive Bladder

    Nov 1, 2015, 00:00

  • The Budget Impact Analysis of Adjunctive Therapy for Patients With Partial Epilepsy

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Sunitinib As Second-Line Treatment For Gastrointestinal Stromal Tumor(Gist) In China

    Nov 1, 2015, 00:00

  • The Contribution of Informal Caregiver Burden to Hta In Hematological Cancers In France, Germany, and The Us

    Nov 1, 2015, 00:00

  • Cost Effectiveness Analysis of Ranibizumab Compared to Aflibercept and Laser Intervention In Treatment of Diabetic Macular Edema (Dme) In The Czech Republic

    Nov 1, 2015, 00:00

  • Prevalence Of Sleeping Pills Consumption And Its Association With Depressive Symptoms

    Nov 1, 2015, 00:00

  • Resource Utilization Among Advanced Squamous and non-Squamous non-Small Cell Lung Cancer Patients Receiving Second-Line Treatment in France, Germany, Italy, and Spain- Results of A Retrospective Medical Chart Review

    Nov 1, 2015, 00:00

  • Compression Therapy Of Venous Insufficiency. Cost And Quantity Characteristics Of Medical Devices In Slovakia 2009 - 2013

    Nov 1, 2015, 00:00

  • Causes And Cost Impact Of Variabilities On The AE Ward Utilization Across Hospitals In Spain

    Nov 1, 2015, 00:00

  • Contraception Patterns In Brazil- 2012 National Survey Data

    Nov 1, 2015, 00:00

  • A Systematic Comparision of Iqwig Recommendations and G-Ba Decisions In The Amnog Process In Germany

    Nov 1, 2015, 00:00

  • An Analysis of German Amnog Re-View Assessments and Learnings for Manufacturers

    Nov 1, 2015, 00:00

  • Reimbursement and Pricing of Innovative Medicines- EU5 Policies and Implications for Market Access

    Nov 1, 2015, 00:00

  • Estimating the Impacts of Medication Adherence and Persistence on Costs and Hospitalization- the Case of Atypical Antipsychotics

    Nov 1, 2015, 00:00

  • Development and Validation of A Conceptual Model of Multiple Myeloma

    Nov 1, 2015, 00:00

  • Economic Evaluation of Saxagliptin in Combination with Metformin Versus Sitagliptin or Vildagliptin in Combination with Metformin in Patients with Type 2 Diabetes in Russia

    Nov 1, 2015, 00:00

  • Patient Beliefs and Preferences in Treatment with Disease Modifying Anti-Rheumatic Drugs

    Nov 1, 2015, 00:00

  • A Quantitative Analysis of Ten Health Technology Assessment (Hta) Agencies for Attributes Driving Transparency of the Organization

    Nov 1, 2015, 00:00

  • An In Silico Health Economic Model Applied to Cryopyrin Associated Periodic Syndromes (Caps)- Cost Effectiveness of Prevention Effects of Ultra-Orphan Drugs for Rare Diseases

    Nov 1, 2015, 00:00

  • A Systematic Review of The Humanistic Burden of Disease In Patients With Fabry Disease

    Nov 1, 2015, 00:00

  • Assessing the Cost-Effectiveness of using Aclidinium Bromide 400 µG /Formoterol Fumarate Dihydrate 12 µG Compared to Aclidinium Bromide 400 µG in the Management of Moderate to Severe Chronic Obstructive Pulmonary Disease

    Nov 1, 2015, 00:00

  • Controlling the Cost Spent on Expensive Biologic Agents- an Example of Net Monetary Savings By Dose Optimisation of Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis Patients

    Nov 1, 2015, 00:00

  • Does Use Of Antipsychotics Increase The Risk Of Death- A Systematic Review And Meta-Analysis Of Observational Studies

    Nov 1, 2015, 00:00

  • Effectiveness and Safety of New and Traditional Oral Anticoagulants in a Population-Based Cohort of New Users with Atrial Fibrillation

    Nov 1, 2015, 00:00

  • Published Diagnostic Discordance Of Lymphoma And Potential For Impact On Patient Care

    Nov 1, 2015, 00:00

  • Real World Evidence And Costs Of Chronic Heart Failure- Findings From 41,413 Patients Of The Arno Database

    Nov 1, 2015, 00:00

  • External And Internal Reference Pricing As Cost Containment Measures In Bulgaria

    Nov 1, 2015, 00:00

  • Resource Utilisation And Costs In Patients With Post-Stroke Spasticity In The United Kingdom

    Nov 1, 2015, 00:00

  • Tea Consumption and Health-Related Quality of Life In Elderly Adults

    Nov 1, 2015, 00:00

  • An Overview of Reviews of The Clinical Effectiveness of Generic Chronic Disease Self Management Support Interventions

    Nov 1, 2015, 00:00

  • Thrombectomy in the treatment of acute ischemic stroke- what effects do methodological differences in trial design have on comparability of outcomes?

    Nov 1, 2015, 00:00

  • Innovation Ranking in France and Italy- Differences and their Impact on Pricing and Reimbursement Processes

    Nov 1, 2015, 00:00

  • Impact of Drug’s Presentation on Patients’ Perception of Treatment’s Risks Benefits Through New Ordinal Gee Modelling Method- Results from Imi Protect Wp6

    Nov 1, 2015, 00:00

  • Terlipressin Versus Noradrenaline In The Treatment Of Hepatorenal Syndrome – Systematic Review With Meta-Analysis And Full Economic Evaluation

    Nov 1, 2015, 00:00

  • Real-World Data on Multiple Comorbidities Among Patients With Hepatitis C- Considerations for Patient Care And Prognosis

    Nov 1, 2015, 00:00

  • Using Financial Incentives to Motivate Stair Use In A Workplace Setting- Results From A Randomized Controlled Trial

    Nov 1, 2015, 00:00

  • Understanding Key Drivers of Successful Hta Submission — Developing a Model

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Dapagliflozin as Add-on to Metformin for the Treatment of Type 2 Diabetes in Greece

    Nov 1, 2015, 00:00

  • Experiences with Price Competition of Biosimilar Drugs In Hungary in Case of Colony-Stimulating Factor Products

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Pregabalin In The Treatment of Central Neuropathic Pain

    Nov 1, 2015, 00:00

  • Health Related Quality of Life (Hrqol) In Patients Who Have Undergone Colectomy for Ulcerative Colitis- Impacts of Complications Post-Surgery

    Nov 1, 2015, 00:00

  • Cost Effectiveness of Drug Coated Balloon Versus Percutaneous Transluminal Balloon Angioplasty In The Treatment of Peripheral Arterial Disease In Lower Limbs In Brazil

    Nov 1, 2015, 00:00

  • Evaluating Diabetes Patients’ Preferences for Profiles of Glp-1 Treatments In The United Kingdom- A Discrete Choice Experiment

    Nov 1, 2015, 00:00

  • A Retrospective Analysis of Time to Market Access and the Regional Impact of Spanish ‘Place in Therapy’ Reports

    Nov 1, 2015, 00:00

  • How to Institutionalize The “Knowledge to Action” Framework for Health Technology Assessment?

    Nov 1, 2015, 00:00

  • Clinical Responses and Improvements in Patient-Reported Outcomes are Associated with Increased Productivity in the Workplace and at Home in Axial Spondyloarthritis Patients Treated with Certolizumab Pegol

    Nov 1, 2015, 00:00

  • Review of Adherence Measures for use in Phase Iv Studies and Recommendations for a new Standardized Generic Measure

    Nov 1, 2015, 00:00

  • Newer Antiepileptic Drugs Dispensed By Community Pharmacies- Generic Prescribing and Cost

    Nov 1, 2015, 00:00

  • Cost Effectiveness of Bortezomib, Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for the First-Line Treatment of Mantle Cell Lymphoma not Eligible for Stem Cell Transplantation- a Scottish Perspective

    Nov 1, 2015, 00:00
  • «
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86 (current)
  • 87
  • 88
  • 89
  • 90
  • »